Systematic Monitoring of Disease Activity Using an Outcome Measure Improves Outcomes in Rheumatoid Arthritis

REFERENCES

1. 1.↵
   1. Josef S,
   2. Danial A,
   3. Klaus M

   . Therapeutic strategies in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2005; 29:163–77.

   OpenUrl
2. 2.↵
   1. van der Heijde DM,
   2. van ’t Hof MA,
   3. van Riel PL,
   4. Theunisse LA,
   5. Lubberts EW,
   6. van Leeuwen MA,
   7. et al.

   Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990;49:916–20.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Mason JH,
   2. Anderson JJ,
   3. Meenan RF,
   4. Haralson KM,
   5. Lewis-Stevens D,
   6. Kaine JL

   . The rapid assessment of disease activity in rheumatology (RADAR) questionnaire. Validity and sensitivity to change of a patient self-report measure of joint count and clinical status. Arthritis Rheum 1992;35:156–62.

   OpenUrlPubMed
4. 4.↵
   1. Stucki G,
   2. Liang MH,
   3. Stucki S,
   4. Bruhlmann P,
   5. Michel BA

   . A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheum 1995;38:795–8.

   OpenUrlPubMed
5. 5.↵
   1. Prevoo MLL,
   2. van ’t Hof MA,
   3. Kuper HH,
   4. van Leeuwen MA,
   5. van de Putte LB,
   6. van Riel PLCM

   . Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8.

   OpenUrlPubMed
6. 6.↵
   1. Felson DT,
   2. Anderson JJ,
   3. Boers M,
   4. Bombardier C,
   5. Furst D,
   6. Goldsmith C,
   7. et al.

   American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727–35.

   OpenUrlPubMed
7. 7.↵
   1. Van Gestel AM,
   2. Prevoo MLL,
   3. van ’t Hof MA,
   4. van Rijswijk MH,
   5. van de Putte LBA,
   6. van Riel PLCM

   . Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria. Arthritis Rheum 1996;39:34–40.

   OpenUrlPubMed
8. 8.↵
   1. Visser K,
   2. Katchamart W,
   3. Loza E,
   4. Martinez-Lopez JA,
   5. Salliot C,
   6. Trudeau J,
   7. et al.

   Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3e Initiative. Ann Rheum Dis 2009;68:1086–93.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Katchamart W,
   2. Bourré-Tessier J,
   3. Donka T,
   4. Drouin J,
   5. Rohekar G,
   6. Bykerk V,
   7. et al.

   Canadian recommendation for use of methotrexate in patients with rheumatoid arthritis. J Rheumatol 2010;37:1422–30.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. van Tulder M,
    2. Furlan A,
    3. Bombardier C,
    4. Bouter L

    . Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine 2003;28:1290–9.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Grigor C,
    2. Capell H,
    3. Stirling A,
    4. McMahon AD,
    5. Lock P,
    6. Vallance R,
    7. et al.

    Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;264:263–9.

    OpenUrl
12. 12.↵
    1. Fransen J,
    2. Moens HB,
    3. Speyer I,
    4. van Riel PLCM

    . Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial. Ann Rheum Dis 2005;64:1294–8.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Verstappen SMM,
    2. Jacobs JWG,
    3. van der Veen MJ,
    4. Heurkens AHM,
    5. Schenk Y,
    6. ter Borg EJ,
    7. et al.

    Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 2007;66:1443–9.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Sackett DL RW,
    2. Rosenberg WM,
    3. Haynes RB

    . Evidence-based medicine: How to practice and teach EBM. London (UK): Churchill Livingstone; 1997.
15. 15.↵
    1. Higgins J,
    2. Green S

    1. Lefebvre C,
    2. Manheimer E,
    3. Glanville J

    . Searching for studies. In: Higgins J, Green S, editors. Cochrane handbook for systematic reviews of interventions version 500 [updated February 2008]. The Cochrane Collaboration; 2008; available from: www.cochrane-handbook.org